Company / Capital Expenditures
HERBALIFE LTD. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$80.4M
FY2025
5-year range
$80.4M / $156.4M
FY2021-FY2025
Trend
-34.1%
vs FY2024
Sector context
#71 of 151
Health Care
What the data says
At $80M, HERBALIFE LTD.'s capital expenditures ranks #71 of 151 in the Health Care sector. Capital Expenditures has declined for 3 consecutive years, from $156M in FY2022 to $80M in FY2025.
Based on SEC 10-K filings.
$80M in FY2025 with a 5-year CAGR of -0.9%.
Declined from $151M to $80M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -19.9%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
#71 of 151 in Health CareTop 47% of 151This company $80.4M Sector average $271.7M
▼
-70.4% below sector average
Key checks
Key Insights
- HERBALIFE LTD.'s capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of -0.9%, indicating a declining trend.
- In FY2025, capital expenditures decreased 34.1% year-over-year.
- Ranks #71 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $80.4M | -34.1% |
| FY2024 | $122.0M | -19.4% |
| FY2023 | $151.4M | -3.2% |
| FY2022 | $156.4M | +47.4% |
| FY2021 | $106.1M | +26.3% |
| FY2020 | $84.0M | -12.0% |
| FY2019 | $95.5M | -33.4% |
| FY2018 | $143.4M | +81.5% |
| FY2017 | $79.0M | -54.5% |
| FY2016 | $173.7M | +18.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026